🇺🇸 FDA
Patent

US 11389444

Methods of treating metabolic diseases with fused bicyclic pyrazoles

granted A61KA61K31/437A61K31/451

Quick answer

US patent 11389444 (Methods of treating metabolic diseases with fused bicyclic pyrazoles) held by Belite Bio, Inc expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Belite Bio, Inc
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/437, A61K31/451, A61K31/4523, A61K31/4535